274 related articles for article (PubMed ID: 37426447)
1. Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma.
Nisnboym M; Vincze SR; Xiong Z; Sneiderman CT; Raphael RA; Li B; Jaswal AP; Sever RE; Day KE; LaToche JD; Foley LM; Karimi H; Hitchens TK; Agnihotri S; Hu B; Rajasundaram D; Anderson CJ; Blumenthal DT; Pearce TM; Uttam S; Nedrow JR; Panigrahy A; Pollack IF; Lieberman FS; Drappatz J; Raphael I; Edwards WB; Kohanbash G
Cancer Res Commun; 2023 Jul; 3(7):1173-1188. PubMed ID: 37426447
[TBL] [Abstract][Full Text] [Related]
2. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
3. Using CD69 PET Imaging to Monitor Immunotherapy-Induced Immune Activation.
Edwards KJ; Chang B; Babazada H; Lohith K; Park DH; Farwell MD; Sellmyer MA
Cancer Immunol Res; 2022 Sep; 10(9):1084-1094. PubMed ID: 35862229
[TBL] [Abstract][Full Text] [Related]
4. [
Gallegos CA; Lu Y; Clements JC; Song PN; Lynch SE; Mascioni A; Jia F; Hartman YE; Massicano AVF; Houson HA; Lapi SE; Warram JM; Markert JM; Sorace AG
Theranostics; 2024; 14(3):911-923. PubMed ID: 38250045
[No Abstract] [Full Text] [Related]
5. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [
Nagle VL; Henry KE; Hertz CAJ; Graham MS; Campos C; Parada LF; Pandit-Taskar N; Schietinger A; Mellinghoff IK; Lewis JS
Clin Cancer Res; 2021 Apr; 27(7):1958-1966. PubMed ID: 33495310
[TBL] [Abstract][Full Text] [Related]
6. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
[TBL] [Abstract][Full Text] [Related]
7. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.
Antonios JP; Soto H; Everson RG; Moughon DL; Wang AC; Orpilla J; Radu C; Ellingson BM; Lee JT; Cloughesy T; Phelps ME; Czernin J; Liau LM; Prins RM
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10220-10225. PubMed ID: 28874539
[TBL] [Abstract][Full Text] [Related]
8. Immuno-PET Monitoring of CD8
Alsaid H; Cheng SH; Bi M; Xie F; Rambo M; Skedzielewski T; Hoang B; Mohanan S; Comroe D; Gehman A; Hsu CY; Farhangi K; Tran H; Sherina V; Doan M; Groseclose MR; Hopson CB; Brett S; Wilson IA; Nicholls A; Ballas M; Waight JD; Jucker BM
Mol Imaging Biol; 2023 Jun; 25(3):528-540. PubMed ID: 36266600
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Biodistribution of
Ghosh S; Fletcher NL; Huda P; Houston ZH; Howard CB; Lund ME; Lu Y; Campbell DH; Walsh BJ; Thurecht KJ
Mol Pharm; 2023 Mar; 20(3):1549-1563. PubMed ID: 36602058
[TBL] [Abstract][Full Text] [Related]
10. Monitoring CD8a
Kristensen LK; Christensen C; Alfsen MZ; Cold S; Nielsen CH; Kjaer A
Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes.
Quan Z; Han Z; Yang Y; Wang J; Wang H; Yang L; A R; Hu X; Wang J; Li X; Li X; Yu H; Chen W; Wang K; Sun X
J Nucl Med; 2024 Jan; 65(1):25-32. PubMed ID: 37973186
[TBL] [Abstract][Full Text] [Related]
12. ImmunoPET imaging of TIGIT in the glioma microenvironment.
Vincze SR; Jaswal AP; Frederico SC; Nisnboym M; Li B; Xiong Z; Sever RE; Sneiderman CT; Rodgers M; Day KE; Latoche JD; Foley LM; Hitchens TK; Frederick R; Patel RB; Hadjipanayis CG; Raphael I; Nedrow JR; Edwards WB; Kohanbash G
Sci Rep; 2024 Mar; 14(1):5305. PubMed ID: 38438420
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography imaging with
Kasten BB; Houson HA; Coleman JM; Leavenworth JW; Markert JM; Wu AM; Salazar F; Tavaré R; Massicano AVF; Gillespie GY; Lapi SE; Warram JM; Sorace AG
Sci Rep; 2021 Jul; 11(1):15384. PubMed ID: 34321569
[TBL] [Abstract][Full Text] [Related]
14. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine.
Liu CJ; Schaettler M; Blaha DT; Bowman-Kirigin JA; Kobayashi DK; Livingstone AJ; Bender D; Miller CA; Kranz DM; Johanns TM; Dunn GP
Neuro Oncol; 2020 Sep; 22(9):1276-1288. PubMed ID: 32133512
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis.
Puuvuori E; Shen Y; Hulsart-Billström G; Mitran B; Zhang B; Cheung P; Wegrzyniak O; Ingvast S; Persson J; Ståhl S; Korsgren O; Löfblom J; Wermeling F; Eriksson O
J Nucl Med; 2024 Feb; 65(2):294-299. PubMed ID: 38050119
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.
Mohme M; Schliffke S; Maire CL; Rünger A; Glau L; Mende KC; Matschke J; Gehbauer C; Akyüz N; Zapf S; Holz M; Schaper M; Martens T; Schmidt NO; Peine S; Westphal M; Binder M; Tolosa E; Lamszus K
Clin Cancer Res; 2018 Sep; 24(17):4187-4200. PubMed ID: 29444930
[No Abstract] [Full Text] [Related]
17. Novel Radiotracer for ImmunoPET Imaging of PD-1 Checkpoint Expression on Tumor Infiltrating Lymphocytes.
Natarajan A; Mayer AT; Xu L; Reeves RE; Gano J; Gambhir SS
Bioconjug Chem; 2015 Oct; 26(10):2062-9. PubMed ID: 26307602
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
[No Abstract] [Full Text] [Related]
19. Implication of CD69
Kim HD; Jeong S; Park S; Lee YJ; Ju YS; Kim D; Song GW; Lee JH; Kim SY; Shin J; Shin EC; Hwang S; Yoo C; Park SH
Liver Int; 2021 Apr; 41(4):764-776. PubMed ID: 33548061
[TBL] [Abstract][Full Text] [Related]
20. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.
Mayer KE; Mall S; Yusufi N; Gosmann D; Steiger K; Russelli L; Bianchi HO; Audehm S; Wagner R; Bräunlein E; Stelzl A; Bassermann F; Weichert W; Weber W; Schwaiger M; D'Alessandria C; Krackhardt AM
Theranostics; 2018; 8(21):6070-6087. PubMed ID: 30613283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
